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Abstract 
Purpose: To investigate the interaction between quinine and Garcinia kola using an in vitro adsorption 
study. 
Methods: In vitro interaction between quinine and G. kola was conducted at 37 ± 0.1 °C. Adsorption of 
quinine (2.5 - 40 µg/ml) to 2.5 % w/v G. kola suspension was studied. Thereafter, quinine desorption 
process was investigated. The amount of quinine adsorbed and desorbed was quantified using HPLC. A 
Freundlich isotherm was constructed to describe the resulting data and percentage of quinine desorbed 
was determined from the desorption data. 
Results: An adsorption isotherm of the data gave a Freundlich constant (K) of 52.66 µg/g, with a slope 
of 0.69 indicating a high capacity and affinity of G. kola to adsorb quinine at a concentration smaller 
than 2.41 µg/g of G. kola.  However the adsorptive capacity of G. kola for quinine at 37 ± 0.1 °C appears 
to be a saturable process as observed from the isotherm. Quinine desorption from G. kola peaked at 1 
hour (37.51 %) and decreased to a constant amount (about 35 %) over the remaining sampling time.  
Conclusion: Quinine is adsorbed on G. kola in vitro. This suggests that concurrent administration of 
quinine and G. kola should be avoided, to prevent potential drug interaction and decreased drug 
bioavailability. 
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Assessment of the in vitro potential of natural 
products to interact with drugs especially when 
taken concurrently has important implications for 
predicting the likelihood of natural product-drug 
interactions or a possible mechanism of 
interaction. Garcinia kola seed, also commonly 
called bitter kola, is a natural product relevant in 
Africa traditional medicine, as well as in cultural 
and social ceremonies in many parts of West and 
Central Africa [1]. The seeds or seed extracts 
(alone or in combination with other 
phytochemicals) are available as proprietary 
dietary supplements [2]. Owing to its acclaimed 
health benefits relevant to the management and 
chemoprevention of some life-threatening 
diseases related to the liver and lungs, and as an 
anti-infective agent, the seeds are usually eaten 
as snack [1,2].  
 
In spite of being a common masticatory nut, not 
much has been reported on its possible 
interaction with prescription drugs in humans. 
Previous in vitro and in vivo studies have 
suggested that G. kola seeds or its extracts have 
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the potential to modulate the activities of some 
drug metabolising enzymes [3-5]. Some authors 
have reported that G. kola reduced ciprofloxacin 
absorption in vitro [6], and reduced both the Cmax 
and AUC when co-administered with ofloxacin in 
humans [4,5]. Some authors have also reported 
a herb - drug interaction in which a Kampo 
preparation which contains various herbal 
medicines and metal cations such as calcium, 
magnesium and aluminum caused significant 
reduction in plasma tetracycline and ciprofloxacin 
concentrations in healthy volunteers through 
complex formation [8,9]. 
 
A significant pharmacokinetic interaction 
between quinine (an antimalarial medicine) and 
G. kola in healthy volunteers has earlier been 
reported and the results were suggestive of 
interference with quinine absorption since 
parameters indicative of interference with 
elimination were not significantly altered [7]. This 
report, coupled with the fact that knowledge of 
the mechanism by which food-drug interactions 
occur may contribute to predicting and 
preventing unwanted alterations in the 
pharmacokinetic profile of drugs [10], formed the 
rationale for the present study which investigated 
a possible mechanism of interaction between 





Chemicals and reagents 
 
Quinine sulphate powder was purchased from 
BDH Chemicals (Poole, UK). HPLC grade 
acetonitrile, methanol, perchloric acid, 
hydrochloric acid, potassium phosphate 
monobasic, and sodium hydroxide were from 
Sigma-Aldrich (Steinheim, Germany). Fresh 
Garcinia kola seeds were purchased locally from 
a retail market in Ile-Ife, Nigeria and were 
identified by Mr G. Ademoriyo, a taxonomist in 
the Herbarium of the Department of Botany, 
Obafemi Awolowo University, Nigeria. A voucher 
specimen (voucher number IFE-17478) was 
deposited at the Herbarium. 
 
HPLC analysis of quinine 
 
Quinine analysis was performed using a 
validated HPLC method as previously reported 
[7]. The HPLC equipment (Agilent 1200 series, 
Agilent Technologies, Santa Clara, California) 
was fitted with an isocratic pump (model 
G1341A) coupled to a variable wavelength 
detector [Agilent Technologies; standard version 
(model G1341B)]. Mobile phase consisted of 
methanol: acetonitrile: 0.02 M potassium 
dihydrogen phosphate (volume ratio 15:15:70), 
and 74 mmol/L perchloric acid (0.64 ml), 
adjusted to pH 2.6 with 10 M NaOH. It was 
pumped through the column (Eclipse XDB-C18 
reverse phase; 5μm particle size and 150 x 4.6 
mm, i.d., Agilent Technologies, Santa Clara, 
California) at a flow rate of 1.6 ml/min at ambient 
temperature while monitoring the effluent at 254 
nm. Quinine stock (1 mg/ml) was prepared by 
dissolving 50 mg of the pure quinine powder in 
50 ml of 0.1 M HCl. Further dilutions were made 
to obtain calibration concentration ranging from 
2.5 - 80 µg/ml. A volume of 20 µl of each 
calibration concentration was injected in 
triplicate, and the mean of the peak area was 
used to generate a calibration curve. 
 
Preparation of G. kola suspension 
 
The husks of G. kola seeds (50 g) were removed 
and the seeds were sliced into small bits, oven-
dried at 40 oC for about 24 h and subsequently 
blended into coarse powder in an electric 
blender. Thereafter, the  powder was transferred 
into a beaker and a small quantity of  0.02 M 
KH2PO4 (pH 5.8) buffer solution was added to 
make a paste which was later transferred into a 2 
L volumetric flask and made up to 2 L with the 
same buffer solution resulting in 2.5 % w/v G. 
kola suspension.  
 
Determination of equilibration time for 
adsorption of quinine on G. kola 
 
Previous methods [11-13] on adsorption of drug 
by antacids and G. kola were adapted. Stock 
solution of quinine (8 ml) containing 1 mg/ml of 
quinine was pipetted into a 100 ml volumetric 
flask and made up to mark with the 2.5 % w/v 
suspension of G. kola. This was mixed in a 
vortex mixer (Parloworld Scientific Ltd, 
Straffordshire, UK) and incubated in a water-bath 
with a shaker at 37 ± 0.1 °C.  Thereafter, the 
suspension (5 ml) was taken at 0.25, 0.5, 1, 2, 3, 
4, 5, 6 and 8 h and centrifuged at 3000 g for 5 
min. The concentrations of quinine in the 
supernatants were then determined using HPLC. 
From the peak area obtained at the various time 
points, the corresponding concentrations of the 
drug in the supernatants were estimated from a 
calibration curve. Subsequently adsorption 
equilibration time was determined from a plot of 
the concentration of the quinine in supernatant 
against time. 
 
Adsorption of quinine on G. kola 
 
Duplicate series of 100 ml flasks containing 
aliquots (0.25, 0.5, 1.0, 2.0 and 4.0 ml) of 1 
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mg/ml quinine solution were prepared. G. kola 
suspension (2.5 % w/v) in 0.02 M KH2PO4 buffer 
was added to the respective flask to a final 
volume of 100 ml mixture. All flasks were 
incubated in a thermostated water bath with 
shaker at 37 ± 0.1 °C for 5 h (equilibration 
experiment showed that after 5 h, no further 
adsorption changes occurred in the quinine - G. 
kola suspension system). Thereafter, 5 ml was 
taken from each of the flasks, centrifuged and 
the concentration of quinine in the respective 
supernatant determined using HPLC. The 
amount of quinine adsorbed was determined by 
subtracting the amount of quinine in supernatant 
from the initial amount of quinine in the mixture. 
Adsorption percentage (%) was derived from the 
difference of the initial concentration of quinine 
(Co) and equilibrium concentration of quinine in 
the supernatant (Ce) using the equation:  
 
Adsorption %= (Co-Ce)/Co × 100 % ……….. (1) 
 
An adsorption isotherm was also generated.  The 
adsorption isotherm of quinine on G. kola at 37 ± 
0.1 °C expressed by a double logarithm plot 
based on Freundlich model was derived from the 
equation:  
 
log x/m = log K + 1/n (logCe) ……………….. (2) 
 
where x is the mass of the quinine adsorbed by 
m grams of G. kola (adsorbent), K is the 
Freundlich constant representing the quinine 
adsorbed per gram of the G. kola at a µg/ml 
quinine concentration, log K is the intercept, 1/n 
is the slope which represents the amount of 
quinine adsorbed for a given concentration 




Elution of the adsorbed quinine by G. kola was 
performed by preparing a concentration of 80 
μg/ml solution of quinine in 2.5 % w/v G. kola 
suspension (100ml). This was equilibrated in a 
thermostated water bath at 37 ± 0.1 °C for 5 h. 
Thereafter, the suspension was centrifuged, and 
the concentration of quinine in the supernatant 
measured using HPLC. Quinine concentration in 
the sediment was calculated from a difference in 
the initial concentration of quinine (80 μg/ml) and 
the concentration in the supernatant. The 
sediment was then dispersed in 100 ml of 0.1 M 
HCl; the flasks were shaken and aliquots of 5 ml 
were removed at 0, 0.25, 0.5, 1, 2, 4, 6, and 8 h 
and centrifuged. The amounts of quinine in the 
new supernatants were determined from the 
calibration curve, and the percentage of quinine 
desorbed was calculated as the ratio of the 
concentration of quinine in the supernatant and 
the concentration of quinine in the sediment 




Adsorption and desorption of quinine on G. 
kola 
 
The standard curve gave a coefficient of 
determination (R2) of 0.9999 for quinine in 0.1 M 
HCl at concentrations between 1.25 and 80 
µg/ml with the regression equation: 
 
y = 41.628x - 10.858.  
 
A plot of the concentration of quinine in the 
supernatant against time (Figure 1) clearly 
revealed that the adsorption equilibration time of 
quinine in the quinine - G. kola suspension was 
between the 4th and 5th hour. 
 
Quinine was adsorbed on G. kola and the 
amount adsorbed increased with increasing 
concentration of quinine (Table 1). At a 
concentration of 10 µg/ml of quinine, the highest 




 Figure 1: Equilibration time curve for the adsorption of quinine on 2.5 % G. kola suspension 
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2.5 1.60 0.90 89.63 35.94 0.21 1.56 35.85 
5 2.25 2.75 275.25 110.63 0.35 2.04 55.05 
10 3.63 6.37 636.64 257.23 0.56 2.41 63.66 
20 11.73 8.27 827.09 337.59 1.07 2.53 41.35 
40 30.33 9.67 966.81 402.84 1.48 2.61 24.17 
Co = Concentration of quinine before adsorption; Ce = concentration of quinine in supernatant after adsorption. x 
= Amount of Quinine adsorbed; m = 2.5g of G. kola suspension/100 ml of suspension; x/m = maximum 
adsorption capacity in µg/g 
 
 
Figure 2: Freundlich adsorption Isotherm for adsorption of quinine on 2.5 % G. kola suspension 
 
The adsorption isotherm of quinine onto G. kola 
at 37.1 oC is shown in Figure 2. The Freundlich 
constant (K) and the slope (1/n) which represents 
the amount of quinine adsorbed for a given 
concentration change were 52.66 µg/g and 0.69 
respectively. 
 
Desorption data of quinine on 2.5 % G. kola is 
presented in Table 2.The amount of quinine 
eluted increased from 30.12 % at 0.25 h and 
peaked to 37.51 % at 1 h. Thereafter, the amount 
desorbed decreased from the 2 h sample and 
remained relatively constant (35.77 to 35.426 %) 
through the remaining sample time point. 
 
Table 2: Desorption data forquinine from 2.5 % G. 
kola suspension 
 











Interaction of quinine with G. kola has been 
demonstrated in this in vitro study to occur as a 
result of capacity-limited adsorption of the drug 
unto G. kola. Numerous factors may have aided 
G. kola in its capacity to absorb quinine. In the 
first place, G. kola is known to contain flavonoids 
[14] which have functional groups that may 
favour complex formation with some compounds 
[15]. Secondly, G. kola also contains trace 
elements or minerals such as calcium, aluminum, 
magnesium, potassium, sodium, zinc and copper 
[16], some of which are known to cause drug 
interactions through chelate formation [8,17]. It is 
known that quinine may also act as a ligand by 
forming a stable five-membered ring with some 
metals through the quinuclidinic nitrogen and the 
hydroxyl oxygen, or by binding through the 
quinolinic aromatic nitrogen [18].  
 
From a plot of the adsorption isotherm, 0.69 and 
52.66 µg/g were obtained for slope (1/n) and K, 
respectively. The slope of the adsorption 
isotherm is dependent on the linearity of the 
isotherm, usually varies between 0 and 1 [11] 
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and provides information on the adsorption 
intensity between quinine and G. kola.  These 
isotherm values decrease with increasing 
intensity of drug adsorption, while large values 
suggest that the adsorbent has a high capacity 
for the adsorbate [19,20].  In the present study, 
the Freundlich linear isotherm profile suggests a 
slope indicative of weak intensity in interaction 
between quinine and G. kola. Although a close 
observation of the isotherm plot showed initial 
linearity at lower values of log x/m suggestive of 
intense interaction at concentrations less than 
2.41 µg quinine per gram of G. kola (Table 1), 
the observed K for the overall data, however, 
indicates a mild adsorption capacity of the G. 
kola for quinine [11]. Desorption data (Table 2) 
showed that no appreciable change occurred 
after the second hour during which the elution of 
quinine attained equilibrium in the system. On 
the basis of these results and what is known 
about the constituents of G. kola [8,17,18], it 
appears that the adsorption of quinine on G. kola 
may have occurred by physical adsorption and 
perhaps by some degree of chemisorption.  
 
The findings from this in vitro study corroborate 
our earlier in vivo report of a pharmacokinetic 
drug interaction between quinine and G. kola 
when ingested concurrently. In this study, we 
aimed at using the same G. kola concentration 
as in our in vivo study since one goal of an in 
vitro study is to simulate experimental conditions 
as close as possible to what is obtained in vivo. 
In order to obtain an in vitro experimental 
condition close to the earlier in vivo study in 
fasting healthy volunteers, the estimated volume 
of intestinal fluid and the amount of G. kola used 
in the in vivo study [7] were also put into 
consideration in determining concentration of G. 
kola used.  About 12.5 g of G. kola was used in 
our human studies. It has been reported that the 
average volume of intestinal fluid in a fasted 
individual is about 500 ml [21,22]. Thus 2.5 % 
w/v of G. kola suspension was employed so as to 
simulate the dose used in the in vivo study. In the 
in vivo study, the time lag required to reach 
maximum plasma concentration (Tmax) increased 
by about 48 %, with a significant reduction in 
maximum plasma concentration (Cmax) and a 
non-significant decrease in area under the 
plasma concentration-time curve, AUC [7]. These 
in vivo findings were suggestive of interferences 
with the absorption of quinine. Indeed, the results 
of this present adsorption-desorption 
experiments make it apparent that quinine is 
adsorbed on G. kola. Since G. kola is a popular 
snack in the tropics, especially in West African 
region where malaria is also endemic, the 
interaction between quinine and G. kola may 
have decrease bioavailability of quinine and 




The results of this in vitro study clearly 
demonstrate that quinine is adsorbed on G. kola 
and it may be necessary to avoid concurrent 
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